Lifecore Biomedical Stock

Lifecore Biomedical EBIT

The EBIT of Lifecore Biomedical (LFCR) as of Aug 10, 2026 is -1.26 M USD. In the previous year, EBIT was -16.84 M USD — a change of -92.54% (higher).

EBIT

-1.26 MUSD

YoY

-92.54%

Last updated:

In 2026, Lifecore Biomedical's EBIT was -1.26 M USD, a -92.54% increase from the -16.84 M USD EBIT recorded in the previous year.

The Lifecore Biomedical EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2023
-5.22 base
Jan 1, 2024
27.60 base
Jan 1, 2025
-16.84 base
Jan 1, 2026
-1.26 base
Jan 1, 2027 (e)
-10.28 base
Jan 1, 2028 (e)
-10.96 base
Jan 1, 2029 (e)
-12.65 base
Jan 1, 2030 (e)
-15.36 base
YEAREBIT (M USD)
2030 est -15.36
2029 est -12.65
2028 est -10.96
2027 est -10.28
2026 -1.26
2025 -16.84
2024 27.60
2023 -5.22
2022 -34.84
2021 -8.82
2020 -26.00
2019 8.87
2018 11.85
2017 15.51
2016 -19.79
2015 18.46
2014 20.19
2013 24.87
2012 14.58
2011 8.03
2010 11.71
2009 12.60
2008 15.18
2007 30.37
Access this data via the Eulerpool API

Lifecore Biomedical Revenue

Lifecore Biomedical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
111.27 M USD
-5.22 M USD
-116.72 M USD
Jan 1, 2024
128.26 M USD
27.60 M USD
12.01 M USD
Jan 1, 2025
128.87 M USD
-16.84 M USD
-38.72 M USD
Jan 1, 2026
129.46 M USD
-1.26 M USD
-30.79 M USD
Jan 1, 2027 (e)
122.18 M USD
-10.28 M USD
-36.39 M USD
Jan 1, 2028 (e)
130.24 M USD
-10.96 M USD
-34.30 M USD
Jan 1, 2029 (e)
150.29 M USD
-12.65 M USD
-41.09 M USD
Jan 1, 2030 (e)
182.46 M USD
-15.36 M USD
-22.63 M USD

Lifecore Biomedical Margins

Lifecore Biomedical stock margins

The Lifecore Biomedical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Lifecore Biomedical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Lifecore Biomedical.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
35.11 %
-4.69 %
-104.89 %
Jan 1, 2024
32.63 %
21.52 %
9.37 %
Jan 1, 2025
31.27 %
-13.07 %
-30.04 %
Jan 1, 2026
31.37 %
-0.97 %
-23.78 %
Jan 1, 2027 (e)
31.37 %
-8.42 %
-29.78 %
Jan 1, 2028 (e)
31.37 %
-8.42 %
-26.33 %
Jan 1, 2029 (e)
31.37 %
-8.42 %
-27.34 %
Jan 1, 2030 (e)
31.37 %
-8.42 %
-12.40 %

Lifecore Biomedical Stock analysis

What does Lifecore Biomedical do? Landec Corp is a US-American company specialized in the development, manufacturing, and marketing of innovative products in the Agribusiness and Biotechnology sectors. It was founded in 1986 as a spin-off from the engineering faculty of Stanford University. The company follows a unique business model based on the integration of advanced technologies and biological processes. This aims to achieve sustainable agriculture that is both mindful of natural resources and achieves high yields. One of Landec's main divisions is the Fresh-Cut Products segment, where the company produces a variety of high-quality salads, vegetable, and fruit snacks that are distributed under the brand Eat Smart®. These products are known for their freshness, taste, and healthy nutritional values, and have gained high recognition in the USA. Another important business division of Landec is the Apio Packaging segment, specialized in the manufacturing and marketing of innovative packaging solutions for fresh fruits and vegetables. The packaging, distributed under the brand BreatheWay®, is equipped with a unique technology that regulates gas exchange within the package and extends the shelf life of the contents. In addition to these core segments, Landec is also active in the field of Biotechnology. Here, the company develops innovative products and technologies for use in human healthcare as well as the agricultural industry. An example of this is Apio's recently introduced whole plant juice called GreenWise™. Landec Corp is known for its innovation capabilities and its ability to develop new products and technologies. Throughout its history, the company has acquired a number of patents and awards and constantly strives to improve and advance its products. Overall, Landec Corp is a company that focuses on sustainability, innovation, and quality. With its unique business model and wide range of products and services, the company is well-positioned to continue growing and expanding its leadership position in the agriculture and biotechnology industry. Lifecore Biomedical is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Lifecore Biomedical's EBIT

Lifecore Biomedical's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Lifecore Biomedical's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Lifecore Biomedical's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Lifecore Biomedical’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Lifecore Biomedical stock

EBIT of Lifecore Biomedical is -1.26 M USD in 2026.

EBIT of Lifecore Biomedical changed from -16.84 M USD to -1.26 M USD, representing a -92.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Lifecore Biomedical since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Lifecore Biomedical historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Lifecore Biomedical

All Key Metrics — Lifecore Biomedical